Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

Valeant adds member to board of directors

President of ValueAct Capital G. Mason Morfitadded to team

- PMLiVE

Novartis’ Cosentyx on course for new European indications

CHMP recommends its approval to treat ankylosing spondylitis and psoriatic arthritis

Bristol-Myers Squibb (BMS) building

First data backs efficacy of BMS’ novel HIV drug

Could provide new treatment for those resistant to antiretroviral therapy

- PMLiVE

AZ moves a step closer to gout drug approval in US

Final verdict to be delivered in end of December

- PMLiVE

Beyond the blind spots in compliance

How to create the right culture

- PMLiVE

A winning launch-readiness strategy

So much more than templates and tick boxes is required

- PMLiVE

Roche appoints new UK general manager

Richard Erwin was previously the company's general manager for Belgium

Executive vice president of Biogen leaves

Tony Kingsley departs the firm

National Institute for Health and Care Excellence NICE logo

NICE backs four treatments for juvenile idiopathic arthritis

Includes BMS' Orencia and AbbVie's Humira

- PMLiVE

The pill branding

An analysis of strategies for female emergency contraceptive pills finds major intercultural differences

Roche Basel Switzerland

Roche’s Kadcyla fails in gastric cancer trial

Results are a major blow to the firm's ambition of expanding the indications for its breast cancer drug

- PMLiVE

Strategic planning in pharma and avoiding frog soup

Formulating the recipe for a successful strategic plan

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links